Abstract
Inflammation is a key determinant of cardiovascular outcomes, but its role in heart failure is uncertain. In patients with cardiometabolic disease enrolled in the prospective, multicenter ancillary study of CIRT (Cardiovascular Inflammation Reduction Trial), CIRT-CFR (Coronary Flow Reserve to Assess Cardiovascular Inflammation), impaired coronary flow reserve was independently associated with increased inflammation and myocardial strain despite well-controlled lipid, glycemic, and hemodynamic profiles. Inflammation modified the relationship between CFR and myocardial strain, disrupting the association between cardiac blood flow and function. Future studies are needed to investigate whether an early inflammation-mediated reduction in CFR capturing microvascular ischemia may lead to heart failure in patients with cardiometabolic disease.
Original language | English (US) |
---|---|
Pages (from-to) | 141-151 |
Number of pages | 11 |
Journal | JACC: Basic to Translational Science |
Volume | 8 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2023 |
Externally published | Yes |
Keywords
- cardiometabolic disease
- cardiovascular trial coronary flow reserve
- coronary microvascular dysfunction
- heart failure
- inflammation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine